Is GeoVax Labs Stock a Good Investment?
GeoVax Labs Investment Advice | GOVXW |
- Examine GeoVax Labs' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research GeoVax Labs' leadership team and their track record. Good management can help GeoVax Labs navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact GeoVax Labs' business and its evolving consumer preferences.
- Compare GeoVax Labs' performance and market position to its competitors. Analyze how GeoVax Labs is positioned in terms of product offerings, innovation, and market share.
- Check if GeoVax Labs pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about GeoVax Labs' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in GeoVax Labs stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if GeoVax Labs is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine GeoVax Labs Stock
Researching GeoVax Labs' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company had not issued any dividends in recent years.
To determine if GeoVax Labs is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding GeoVax Labs' research are outlined below:
| GeoVax Labs had very high historical volatility over the last 90 days | |
| GeoVax Labs has some characteristics of a very speculative penny stock | |
| GeoVax Labs has a very high chance of going through financial distress in the upcoming years | |
| GeoVax Labs has accumulated 3.52 M in total debt. GeoVax Labs has a current ratio of 0.33, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about GeoVax Labs' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (25.97 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| GeoVax Labs has accumulated about 710.68 K in cash with (25.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.92, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| GeoVax Labs has a frail financial position based on the latest SEC disclosures | |
| Latest headline from MacroaxisInsider: Acquisition by Chase Randal D of 16613 shares of GeoVax Labs at 5.0 subject to Rule 16b-3 |
GeoVax Labs Quarterly Good Will |
|
GeoVax Labs' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (2.80) | (2.94) | |
| Return On Capital Employed | (4.64) | (4.41) | |
| Return On Assets | (2.80) | (2.94) | |
| Return On Equity | (4.51) | (4.28) |
Determining GeoVax Labs' profitability involves analyzing its financial statements and using various financial metrics to determine if GeoVax Labs is a good buy. For example, gross profit margin measures GeoVax Labs' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of GeoVax Labs' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in GeoVax Labs' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of GeoVax Labs. Check GeoVax Labs' Beneish M Score to see the likelihood of GeoVax Labs' management manipulating its earnings.
Evaluate GeoVax Labs' management efficiency
The company has return on total asset (ROA) of (1.3435) % which means that it has lost $1.3435 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (3.6239) %, meaning that it generated substantial loss on money invested by shareholders. GeoVax Labs' management efficiency ratios could be used to measure how well GeoVax Labs manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -2.94 in 2024. Return On Capital Employed is likely to climb to -4.41 in 2024. At this time, GeoVax Labs' Other Current Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to climb to about 1.2 M in 2024, whereas Total Assets are likely to drop slightly above 4.9 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.27 | 2.38 | |
| Tangible Book Value Per Share | 2.27 | 2.38 | |
| Enterprise Value Over EBITDA | (0.27) | (0.29) | |
| Price Book Value Ratio | 2.39 | 2.27 | |
| Enterprise Value Multiple | (0.27) | (0.29) | |
| Price Fair Value | 2.39 | 2.27 | |
| Enterprise Value | 7.3 M | 6.9 M |
The management strategies employed by GeoVax Labs' are designed to enhance shareholder value and ensure long-term growth. We assess the effectiveness of these strategies in our stock analysis.
Beta 3.109 |
Basic technical analysis of GeoVax Stock
As of the 29th of November, GeoVax Labs retains the Risk Adjusted Performance of (0.02), standard deviation of 18.46, and Market Risk Adjusted Performance of (3.51). GeoVax Labs technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out GeoVax Labs information ratio, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if GeoVax Labs is priced fairly, providing market reflects its last-minute price of 0.12 per share. As GeoVax Labs appears to be a penny stock we also urge to confirm its jensen alpha numbers.GeoVax Labs' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific GeoVax Labs insiders, such as employees or executives, is commonly permitted as long as it does not rely on GeoVax Labs' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases GeoVax Labs insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Chase Randal D six days ago Acquisition by Chase Randal D of 16613 shares of GeoVax Labs at 5.0 subject to Rule 16b-3 | ||
Mcnally Robert T over a month ago Acquisition by Mcnally Robert T of 50000 shares of GeoVax Labs at 0.755 subject to Rule 16b-3 | ||
Reynolds Mark over six months ago Acquisition by Reynolds Mark of 10000 shares of GeoVax Labs at 0.17 subject to Rule 16b-3 |
Understand GeoVax Labs' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing GeoVax Labs' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (3.51) | |||
| Mean Deviation | 13.58 | |||
| Coefficient Of Variation | (2,568) | |||
| Standard Deviation | 18.46 | |||
| Variance | 340.61 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.75) | |||
| Total Risk Alpha | (3.51) | |||
| Treynor Ratio | (3.52) | |||
| Maximum Drawdown | 94.26 | |||
| Value At Risk | (26.67) | |||
| Potential Upside | 28.57 | |||
| Skewness | 0.6727 | |||
| Kurtosis | 1.31 |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (3.51) | |||
| Mean Deviation | 13.58 | |||
| Coefficient Of Variation | (2,568) | |||
| Standard Deviation | 18.46 | |||
| Variance | 340.61 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.75) | |||
| Total Risk Alpha | (3.51) | |||
| Treynor Ratio | (3.52) | |||
| Maximum Drawdown | 94.26 | |||
| Value At Risk | (26.67) | |||
| Potential Upside | 28.57 | |||
| Skewness | 0.6727 | |||
| Kurtosis | 1.31 |
Consider GeoVax Labs' intraday indicators
GeoVax Labs intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of GeoVax Labs stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
GeoVax Labs time-series forecasting models is one of many GeoVax Labs' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary GeoVax Labs' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
GeoVax Stock media impact
Far too much social signal, news, headlines, and media speculation about GeoVax Labs that are available to investors today. That information is available publicly through GeoVax media outlets and privately through word of mouth or via GeoVax internal channels. However, regardless of the origin, that massive amount of GeoVax data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of GeoVax Labs news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of GeoVax Labs relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to GeoVax Labs' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive GeoVax Labs alpha.
GeoVax Labs Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards GeoVax Labs can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
GeoVax Labs Corporate Management
| CPA CPA | CFO Sec | Profile | |
| Mark Newman | Chief Officer | Profile | |
| Jeffrey Welch | Head Operations | Profile | |
| Harriet Robinson | Chief Founder | Profile | |
| John Sharkey | Vice Development | Profile |
Additional Tools for GeoVax Stock Analysis
When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.